Literature DB >> 10702217

Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad.

W A Faubion, W J Sandborn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10702217     DOI： 10.1016/s0016-5085(00)70272-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  8 in total

1.  Probiotics for Crohn's disease: what have we learned?

Authors:  C Prantera
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

2.  Probiotics for maintenance of remission in ulcerative colitis.

Authors:  Zipporah Iheozor-Ejiofor; Lakhbir Kaur; Morris Gordon; Patricia Anne Baines; Vasiliki Sinopoulou; Anthony K Akobeng
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

Review 3.  How important is onset of action in ulcerative colitis therapy?

Authors:  Steven Masson; David Nylander; John C Mansfield
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 5.  Potential role of nutraceutical compounds in inflammatory bowel disease.

Authors:  Tiziana Larussa; Maria Imeneo; Francesco Luzza
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

6.  Serial passage in an insect host indicates genetic stability of the human probiotic Escherichia coli Nissle 1917.

Authors:  Nicolas C H Schröder; Ana Korša; Haleluya Wami; Olena Mantel; Ulrich Dobrindt; Joachim Kurtz
Journal:  Evol Med Public Health       Date:  2022-02-11

7.  Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation.

Authors:  Dong-Xue Lu; Feng Liu; Hua Wu; Hai-Xia Liu; Bing-Yu Chen; Jing Yan; Yin Lu; Zhi-Guang Sun
Journal:  World J Gastroenterol       Date:  2022-08-28       Impact factor: 5.374

8.  Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice.

Authors:  T Hudcovic; R Stepánková; H Kozákova; T Hrncír; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.